About Alida Biosciences
Alida Biosciences is a company based in San Diego (United States) founded in 2020 by Byron Purse. Alida Biosciences has raised $11.52 million across 6 funding rounds from investors including HHS, Genoa Ventures and FusionX Ventures. The company has 17 employees as of December 31, 2024. Alida Biosciences offers products and services including EpiPlex Platform and EpiScout Software. Alida Biosciences operates in a competitive market with competitors including Veracyte, Cajal Neuroscience, HAYA Therapeutics, Cofactor Genomics and Novigenix, among others.
- Headquarter San Diego, United States
- Employees 17 as on 31 Dec, 2024
- Founders Byron Purse
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Alida Biosciences Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.52 M (USD)
in 6 rounds
-
Latest Funding Round
$7.52 M (USD), Series A
Jun 07, 2024
-
Investors
HHS
& 3 more
-
Employee Count
17
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alida Biosciences
Alida Biosciences offers a comprehensive portfolio of products and services, including EpiPlex Platform and EpiScout Software.
Enables mapping and quantifying RNA modifications in sequencing workflows.
Uses machine learning to transform sequencing data into biological insights.
People of Alida Biosciences
Unlock access to complete
Funding Insights of Alida Biosciences
Alida Biosciences has successfully raised a total of $11.52M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $7.52 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Alida Biosciences
Alida Biosciences has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Genoa Ventures and FusionX Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage VC firm focused on life science startups
|
Locked | Locked | Locked | |
|
FusionX Ventures is engaged in early-stage startup investments.
|
Locked | Locked | Locked | |
|
Early-stage venture capital investments are made in specific industry verticals.
|
Locked | Locked | Locked |
Investor details for Alida Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Alida Biosciences
Investment portfolio details for Alida Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Alida Biosciences
Detailed financials for Alida Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Alida Biosciences Comparisons
Peer comparison for Alida Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Alida Biosciences
Alida Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Veracyte, Cajal Neuroscience, HAYA Therapeutics, Cofactor Genomics and Novigenix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are developed.
|
|
| Locked | Locked | Locked |
Neurodegenerative disease drugs are developed through genetic screening and multi-omics.
|
|
| Locked | Locked | Locked |
RNA-based therapies for treating heart diseases are developed.
|
|
| Locked | Locked | Locked |
Diagnostic assays are developed using RNA sequencing technology.
|
|
| Locked | Locked | Locked |
Immuno-transcriptomic technology for cancer precision medicine is developed.
|
Detailed competitors of Alida Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Alida Biosciences
Complete news archive for Alida Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alida Biosciences
Alida Biosciences was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Alida Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Alida Biosciences is a funded company, having raised a total of $11.52M across 6 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Alida Biosciences is 17.
Alida Biosciences was founded in 2020 in San Diego, United States, within the biotechnology sector focused on RNA biology. Technologies for RNA analysis are developed and offered to support the creation of medical treatments and diagnostic assays. Operations center on advancing RNA-based solutions to address health challenges, with a presence in the U.S. research ecosystem.
Alida Biosciences's top competitors include HAYA Therapeutics, Veracyte and Novigenix.
Alida Biosciences offers EpiPlex Platform and EpiScout Software.
Alida Biosciences has 4 investors. Key investors include HHS, Genoa Ventures, FusionX Ventures, and Vertical Venture Partners.